Your browser doesn't support javascript.
loading
Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics.
Matos, Marliette R; Ho, Seok-Man; Schrode, Nadine; Brennand, Kristen J.
Affiliation
  • Matos MR; Graduate School of Biomedical Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States of America.
  • Ho SM; Graduate School of Biomedical Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States of America; Department of Stem Cell and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States of America.
  • Schrode N; Department of Genetics and Genomics, Pamela Sklar Division of Psychiatric Genomics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States of America; Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States of
  • Brennand KJ; Graduate School of Biomedical Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States of America; Department of Stem Cell and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States of America; Department of Genetics and Genomics,
Mol Cell Neurosci ; 107: 103532, 2020 09.
Article de En | MEDLINE | ID: mdl-32712198
ABSTRACT
Neuropsychiatric disorders are highly heritable polygenic disorders arising from the complex interplay of highly penetrant rare variants and common variants of small effect. There is a large index of comorbidity and shared genetic risk between disorders, reflecting the pleiotropy of individual variants as well as predicted downstream pathway-level convergence. Importantly, the mechanism(s) through which psychiatric disease-associated variants interact to contribute to disease risk remains unknown. Human induced pluripotent stem cell (hiPSC)-based models are increasingly useful for the systematic study of the complex genetics associated with brain diseases, particularly when combined with CRISPR-mediated genomic engineering, which together facilitate isogenic comparisons of defined neuronal cell types. In this review, we discuss the latest CRISPR technologies and consider how they can be successfully applied to the functional characterization of the growing list genetic variants linked to psychiatric disease.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Encéphalopathies / Cellules souches pluripotentes induites / Clustered regularly interspaced short palindromic repeats / Troubles mentaux Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Animals / Humans Langue: En Journal: Mol Cell Neurosci Sujet du journal: BIOLOGIA MOLECULAR / NEUROLOGIA Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Encéphalopathies / Cellules souches pluripotentes induites / Clustered regularly interspaced short palindromic repeats / Troubles mentaux Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Animals / Humans Langue: En Journal: Mol Cell Neurosci Sujet du journal: BIOLOGIA MOLECULAR / NEUROLOGIA Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique